glp 1 ro co INTRODUCES ONE-MONTH $199 WEGOVY NEW PATIENT OFFER AND DISCOUNTED BODY MEMBERSHIP Serena’s on @Ro.co, and they’re

While evidence supports behavior modification, compounded GLP-1 medications may address metabolic factors that behavioral interventions alone cannot target

Ozempic, Wegovy and Mounjaro accounted for nearly $4-billion in sales at retail pharmacies in 2025, according to IQVIA Canada

Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) have increasingly been used to treat type 2 diabetes mellitus

In 2020, West Virginia launched a pilot program to subsidize GLP-1 drugs for public employees, but the program was shuttered in March.

The use of branded ingredients allows private label partners to leverage established research narratives, ingredient storytelling, and clinical positioning strategies in their marketing materials

In those years, Wegovy and Mounjaro, respectively, were the highest-volume and highest-utilization drivers of this overall trend.